Literature DB >> 17978847

Both early and late stages of hepatocarcinogenesis are enhanced in Cx32 dominant negative mutant transgenic rats with disrupted gap junctional intercellular communication.

Naomi Hokaiwado1, Makoto Asamoto, Mitsuru Futakuchi, Kumiko Ogawa, Satoru Takahashi, Tomoyuki Shirai.   

Abstract

Connexins are a family of transmembrane proteins essential for the gap junctions, which mediate cell-to-cell communication. Several connexins are reported to be tumor suppressors, and we have established transgenic (Tg) rats with a connexin 32 (Cx32) dominant negative mutant showing high sensitivity to early-stage diethylnitrosamine (DEN)-induced liver carcinogenesis. In this study, we carried out two independent experiments using Tg rats to further investigate the roles of disrupted Cx32 in late-stage carcinogenesis (carcinoma induction and metastasis) in the liver. In the first experiment, of 50 weeks' duration, DEN was administered at 6 weeks of age and at 26 weeks to explore the effects of carcinogen treatments at different stages. The number of hepatocellular carcinomas (HCCs) was significantly increased in Tg compared with non-Tg rats. The second experiment focused on the effects of Cx32 disruption on metastasis by HCCs induced by administration of DEN and N-nitrosomorpholine. Only Tg rats had multiple metastases of HCCs in the lung, and the development and growth of HCCs was dramatically accelerated in Tg compared to non-Tg rats. Thus, normal function of Cx32 may be essential for suppression of both early and late stages of hepatocarcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17978847     DOI: 10.1007/s00232-007-9053-9

Source DB:  PubMed          Journal:  J Membr Biol        ISSN: 0022-2631            Impact factor:   1.843


  22 in total

Review 1.  Structural and functional diversity of connexin genes in the mouse and human genome.

Authors:  Klaus Willecke; Jürgen Eiberger; Joachim Degen; Dominik Eckardt; Alessandro Romualdi; Martin Güldenagel; Urban Deutsch; Goran Söhl
Journal:  Biol Chem       Date:  2002-05       Impact factor: 3.915

Review 2.  Defective gap junctional intercellular communication in the carcinogenic process.

Authors:  Marc Mesnil; Sophie Crespin; José-Luis Avanzo; Maria-Lucia Zaidan-Dagli
Journal:  Biochim Biophys Acta       Date:  2005-11-21

Review 3.  Genetic and epigenetic changes of intercellular communication genes during multistage carcinogenesis.

Authors:  H Yamasaki; Y Omori; M L Zaidan-Dagli; N Mironov; M Mesnil; V Krutovskikh
Journal:  Cancer Detect Prev       Date:  1999

4.  High incidence of spontaneous and chemically induced liver tumors in mice deficient for connexin32.

Authors:  A Temme; A Buchmann; H D Gabriel; E Nelles; M Schwarz; K Willecke
Journal:  Curr Biol       Date:  1997-09-01       Impact factor: 10.834

5.  Morphology and morphometric investigation of hepatocellular preneoplastic lesions and neoplasms in connexin32-deficient mice.

Authors:  Matthias Evert; Thomas Ott; Achim Temme; Klaus Willecke; Frank Dombrowski
Journal:  Carcinogenesis       Date:  2002-05       Impact factor: 4.944

6.  Lack of phenobarbital-mediated promotion of hepatocarcinogenesis in connexin32-null mice.

Authors:  O Moennikes; A Buchmann; A Romualdi; T Ott; J Werringloer; K Willecke; M Schwarz
Journal:  Cancer Res       Date:  2000-09-15       Impact factor: 12.701

Review 7.  Gap junctions as targets for cancer chemoprevention and chemotherapy.

Authors:  J E Trosko; R J Ruch
Journal:  Curr Drug Targets       Date:  2002-12       Impact factor: 3.465

8.  Sequential changes of gap-junctional intercellular communications during multistage rat liver carcinogenesis: direct measurement of communication in vivo.

Authors:  V A Krutovskikh; M Oyamada; H Yamasaki
Journal:  Carcinogenesis       Date:  1991-09       Impact factor: 4.944

9.  WY-14,643-mediated promotion of hepatocarcinogenesis in connexin32-wild-type and connexin32-null mice.

Authors:  Oliver Moennikes; Sabine Stahl; Peter Bannasch; Albrecht Buchmann; Michael Schwarz
Journal:  Carcinogenesis       Date:  2003-06-19       Impact factor: 4.944

10.  Establishment of an in vivo highly metastatic rat hepatocellular carcinoma model.

Authors:  M Futakuchi; M Hirose; T Ogiso; K Kato; M Sano; K Ogawa; T Shirai
Journal:  Jpn J Cancer Res       Date:  1999-11
View more
  8 in total

1.  Connexin 32 dysfunction promotes ethanol-related hepatocarcinogenesis via activation of Dusp1-Erk axis.

Authors:  Hiroyuki Kato; Aya Naiki-Ito; Taku Naiki; Shugo Suzuki; Yoriko Yamashita; Shinya Sato; Hiroyuki Sagawa; Akihisa Kato; Toshiya Kuno; Satoru Takahashi
Journal:  Oncotarget       Date:  2016-01-12

2.  Connexin-based signaling and drug-induced hepatotoxicity.

Authors:  Michaël Maes; Mathieu Vinken
Journal:  J Clin Transl Res       Date:  2017-02-12

Review 3.  The role of gap junctions in inflammatory and neoplastic disorders (Review).

Authors:  Pui Wong; Victoria Laxton; Saurabh Srivastava; Yin Wah Fiona Chan; Gary Tse
Journal:  Int J Mol Med       Date:  2017-01-17       Impact factor: 4.101

Review 4.  Transgenic rat models for mutagenesis and carcinogenesis.

Authors:  Takehiko Nohmi; Kenichi Masumura; Naomi Toyoda-Hokaiwado
Journal:  Genes Environ       Date:  2017-02-01

5.  Lactoferrin Prevents Hepatic Injury and Fibrosis via the Inhibition of NF-κB Signaling in a Rat Non-Alcoholic Steatohepatitis Model.

Authors:  Yoshinaga Aoyama; Aya Naiki-Ito; Kuang Xiaochen; Masayuki Komura; Hiroyuki Kato; Yuko Nagayasu; Shingo Inaguma; Hiroyuki Tsuda; Mamoru Tomita; Yoichi Matsuo; Shuji Takiguchi; Satoru Takahashi
Journal:  Nutrients       Date:  2021-12-23       Impact factor: 5.717

6.  Expression and Functionality of Connexin-Based Channels in Human Liver Cancer Cell Lines.

Authors:  Kaat Leroy; Cícero Júlio Silva Costa; Alanah Pieters; Bruna Dos Santos Rodrigues; Raf Van Campenhout; Axelle Cooreman; Andrés Tabernilla; Bruno Cogliati; Mathieu Vinken
Journal:  Int J Mol Sci       Date:  2021-11-10       Impact factor: 5.923

7.  Localization of connexin 32 in spontaneous liver lesions of mice.

Authors:  Isao Igarashi; Toshihiko Makino; Kiyonori Kai; Munehiro Teranishi; Wataru Takasaki; Hiroshi Satoh; Kazuhisa Furuhama
Journal:  J Vet Med Sci       Date:  2015-08-11       Impact factor: 1.267

8.  A novel model of non-alcoholic steatohepatitis with fibrosis and carcinogenesis in connexin 32 dominant-negative transgenic rats.

Authors:  Aya Naiki-Ito; Hiroyuki Kato; Taku Naiki; Ranchana Yeewa; Yoshinaga Aoyama; Yuko Nagayasu; Shugo Suzuki; Shingo Inaguma; Satoru Takahashi
Journal:  Arch Toxicol       Date:  2020-08-24       Impact factor: 5.153

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.